🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the makers of Tylenol, asserting the corporations concealed safety concerns that the pain reliever created to children's brain development.

This legal action comes thirty days after President Donald Trump publicized an unverified association between consuming Tylenol - referred to as paracetamol - while pregnant and autism in young ones.

The attorney general is taking legal action against J&J, which previously sold the drug, the sole analgesic recommended for pregnant women, and the current manufacturer, which presently makes it.

In a official comment, he said they "misled consumers by making money from pain and marketing drugs regardless of the risks."

The manufacturer says there is no credible evidence linking acetaminophen to autism spectrum disorder.

"These corporations deceived for years, intentionally threatening numerous people to line their pockets," the attorney general, from the Republican party, said.

Kenvue commented that it was "deeply concerned by the dissemination of inaccurate information on the safety of acetaminophen and the likely effects that could have on the welfare of American women and children."

On its official site, the company also stated it had "continuously evaluated the relevant science and there is lacking reliable evidence that indicates a verified association between taking acetaminophen and autism spectrum disorder."

Groups speaking for doctors and health professionals agree.

The American College of Obstetricians and Gynecologists has declared acetaminophen - the key substance in Tylenol - is one of the few options for women during pregnancy to treat discomfort and fever, which can pose major wellness concerns if ignored.

"In more than two decades of investigation on the use of paracetamol in gestation, no reliable research has conclusively proven that the usage of acetaminophen in any period of pregnancy causes neurodevelopmental disorders in offspring," the organization stated.

This legal action cites recent announcements from the former administration in asserting the medication is allegedly unsafe.

Recently, the former president generated worry from public health officials when he instructed women during pregnancy to "resist strongly" not to use Tylenol when unwell.

The FDA then released a statement that physicians should think about restricting the consumption of acetaminophen, while also stating that "a causal relationship" between the drug and autism spectrum disorder in minors has remains unverified.

The Health Department head Robert F Kennedy Jr, who manages the Food and Drug Administration, had promised in spring to initiate "comprehensive study program" that would establish the source of autism spectrum disorder in a limited time.

But authorities cautioned that discovering a unique factor of autism - thought by researchers to be the consequence of a complicated interplay of genetic and environmental factors - would not be simple.

Autism is a category of enduring cognitive variation and impairment that influences how persons experience and engage with the environment, and is recognized using medical professional evaluations.

In his legal document, Paxton - who supports Trump who is campaigning for federal office - alleges Kenvue and Johnson & Johnson "deliberately disregarded and attempted to silence the science" around acetaminophen and autism spectrum disorder.

This legal action attempts to require the corporations "remove any commercial messaging" that claims acetaminophen is secure for women during pregnancy.

The Texas lawsuit echoes the complaints of a collection of guardians of young ones with autism and attention deficit hyperactivity disorder who sued the manufacturers of Tylenol in 2022.

A federal judge threw out the legal action, saying research from the parents' expert witnesses was lacking definitive proof.